Trial Profile
A Single-Blind, Randomized, Parallel Trial to Define the ECG Effects of Sancuso (Granisetron Transdermal System) Compared to Placebo and Moxifloxacin in Healthy Men and Women
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 01 Jun 2012
Price :
$35
*
At a glance
- Drugs Granisetron (Primary) ; Granisetron; Moxifloxacin
- Indications Bacterial infections; Chemotherapy-induced nausea and vomiting
- Focus Adverse reactions; Pharmacodynamics
- Sponsors ProStrakan
- 08 Oct 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 08 Oct 2009 Actual end date (Sep 2009) added as reported by ClinicalTrials.gov.
- 18 Jun 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.